| Runx2: Structure, function, and phosphorylation in osteoblast differentiation S Vimalraj, B Arumugam, PJ Miranda, N Selvamurugan International journal of biological macromolecules 78, 202-208, 2015 | 397 | 2015 |
| Regulation of breast cancer and bone metastasis by microRNAs S Vimalraj, PJ Miranda, B Ramyakrishna, N Selvamurugan Disease markers 35 (5), 369-387, 2013 | 125 | 2013 |
| Regulation of mutant p53 protein expression R Vijayakumaran, KH Tan, PJ Miranda, S Haupt, Y Haupt Frontiers in oncology 5, 284, 2015 | 106 | 2015 |
| The role of MDM2 and MDM4 in breast cancer development and prevention S Haupt, R Vijayakumaran, PJ Miranda, A Burgess, E Lim, Y Haupt Journal of molecular cell biology 9 (1), 53-61, 2017 | 79 | 2017 |
| Targeting Mdmx to treat breast cancers with wild-type p53 S Haupt, D Buckley, JMB Pang, J Panimaya, PJ Paul, C Gamell, ... Cell death & disease 6 (7), e1821-e1821, 2015 | 52 | 2015 |
| miR-590–3p inhibits proliferation and promotes apoptosis by targeting activating transcription factor 3 in human breast cancer cells M Rohini, M Gokulnath, PJ Miranda, N Selvamurugan Biochimie 154, 10-18, 2018 | 51 | 2018 |
| MDM4 is a rational target for treating breast cancers with mutant p53 PJ Miranda, D Buckley, D Raghu, JMB Pang, EA Takano, ... The Journal of Pathology 241 (5), 661-670, 2017 | 43 | 2017 |
| A feedback expression of microRNA-590 and activating transcription factor-3 in human breast cancer cells PJ Miranda, S Vimalraj, N Selvamurugan International journal of biological macromolecules 72, 145-150, 2015 | 42 | 2015 |
| Regulation of mutant p53 protein expression. Front Oncol. 2015; 5: 284 R Vijayakumaran, KH Tan, PJ Miranda, S Haupt, Y Haupt | 8 | |
| ErbB4 in the brain: focus on high grade glioma JL Pitcher, N Alexander, PJ Miranda, TG Johns Frontiers in Oncology 12, 983514, 2022 | 7 | 2022 |
| Targeting MDM4 as a novel therapeutic approach in prostate cancer independent of p53 status JO Mejía-Hernández, D Raghu, F Caramia, N Clemons, K Fujihara, ... Cancers 14 (16), 3947, 2022 | 7 | 2022 |
| Current approaches in tissue engineering-based nanotherapeutics for osteosarcoma treatment PJMNS A Shanmugavadivu, S Lekhavadhani Biomedical Materials, 2024 | 2 | 2024 |
| Neuro-Oncology Advances B Dewdney, PJ Miranda, M Kuchibhotla, R Palanisamy, C Richworth, ... | | 2024 |
| Ion channel modulator DPI-201-106 significantly enhances antitumor activity of DNA damage response inhibitors in glioblastoma B Dewdney, PJ Miranda, M Kuchibhotla, R Palanisamy, C Richworth, ... Neuro-Oncology Advances 6 (1), vdae187, 2024 | | 2024 |
| The role of ion channels in high-grade glioma (HGG) N Miranda, P. J., Richworth, C., & Anderson Journal of Current Oncology and Medical Sciences 4 (2), 2024 | | 2024 |
| WHS Management Tool for AI PJF A Varhammer, S Hussain https://www.centreforwhs.nsw.gov.au/research/whs-management-tool-for-ai, 2023 | | 2023 |
| Combination Treatment T Johns, E Fletcher, PJ Fernando, M Kuchibhotla | | 2022 |
| Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status K Fujihara, T Riseborough, A Teunisse, AG Jochemsen, L Abrahmsén, ... | | 2022 |
| Coates edited ORIGINAL PAPER PJ Miranda, D Buckley, D Raghu, JMB Pang, EA Takano, ... | | |
Nagarajan SelvamuruganSRM UniversityDirección de correo verificada de ktr.srmuniv.ac.in
